Per Hammarström - Concepedia

Author

Per Hammarström

Also Known As

B Bouma, Hammarstrom, Per, Hammarström, Per, P Hammarström, P. HAMMARSTRÖM, P. Hammarstrom, P. Hammarström, Per Hammarstrom, Per Hammarström, Per Hammarstrrm

219

Publications

9.2K

Citations

H-Index

117

Concepts

All Affiliations

Linköping University Norwegian University of Science and Technology Scripps Research Institute Hertie Institute for Clinical Brain Research Uppsala University

About

Per Hammarström is an author at Linköping University specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	39	3.2K
2	Natural Sciences	24	30	2.4K
3	Engineering	11	11	1K
4	Social Sciences	4	4	385
5	Health Sciences	1	1	33

Per Hammarström

104

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics Per Hammarström, R. Luke Wiseman, Evan T. Powers, Science Protein ChemistryAmyloid StateAlzheimer's DiseaseBiochemistryProtein Assembly	2003	520
The Biological and Chemical Basis for Tissue-Selective Amyloid Disease Yoshiki Sekijima, R. Luke Wiseman, Jeanne Matteson, Cell Alzheimer's DiseaseTissue-selective Amyloid DiseaseBiochemistryDegenerative PathologyProtein Misfolding	2005	486
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity Per Hammarström, Xin Jiang, Amy R. Hurshman, Proceedings of the National Academy of Sciences	2002	351
Detection and Characterization of Aggregates, Prefibrillar Amyloidogenic Oligomers, and Protofibrils Using Fluorescence Spectroscopy Mikaël Lindgren, Karin Sörgjerd, Per Hammarström Biophysical Journal Alzheimer's DiseaseBiochemistryProtein MisfoldingProtein Phase SeparationMedicine	2005	341
Novel Pentameric Thiophene Derivatives for <i>in Vitro</i> and <i>in Vivo</i> Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses Andreas Åslund, Christina J. Sigurdson, Therése Klingstedt, ACS Chemical Biology	2009	333
<i>Trans</i> -Suppression of Misfolding in an Amyloid Disease Per Hammarström, Frank Schneider, Jeffery W. Kelly Science	2001	290
Prion strain discrimination using luminescent conjugated polymers Christina J. Sigurdson, K. Peter R. Nilsson, Simone Hornemann, Nature Methods Materials SciencePolymer MaterialEngineeringPolymer ScienceConjugated Polymer	2007	272
Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation Coen Maas, José W.P. Govers‐Riemslag, Barend Bouma, Journal of Clinical Investigation ImmunologyCell DeathPathologyCytoskeletonInflammation	2008	241
An Engineered Transthyretin Monomer that Is Nonamyloidogenic, Unless It Is Partially Denatured Xin Jiang, Craig S. Smith, H. Michael Petrassi, Biochemistry	2001	236
Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease Jay Rasmussen, Jasmin Mahler, Natalie Beschörner, Proceedings of the National Academy of Sciences	2017	221

Page 1